NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00278421,Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma,https://clinicaltrials.gov/study/NCT00278421,,COMPLETED,"RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and kill them or carry cancer-killing substances to them. Others interfere with the ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as cyclophosphamide, doxorubicin, vincristine, and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving rituximab together with combination chemotherapy may kill more cancer cells. It is not yet known which schedule of rituximab and combination chemotherapy is more effective in treating non-Hodgkin's lymphoma.

PURPOSE: This randomized phase III trial is studying two different schedules of rituximab and combination chemotherapy to compare how well they work in treating patients with aggressive B-cell non-Hodgkin's lymphoma.",NO,Lymphoma,BIOLOGICAL: rituximab|DRUG: cyclophosphamide|DRUG: doxorubicin hydrochloride|DRUG: prednisone|DRUG: vincristine sulfate,"Time to treatment failure (TTF) measured from day 1 of course 1 of Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (CHOP) therapy up to 3 years on study with life-long follow-up, through study completion","Complete response (CR) rate duration until first relapse, through study completion|Progression rate during treatment, through study completion|Survival, through study completion|Tumor control measured from day 1 of course 1 of CHOP therapy (non-tumor related events are censored), through study completion|Disease-free survival measured from day 1 of course 1 of CHOP therapy, through study completion|Safety (adverse events, serious adverse events) assessed at 3 months after treatment, through study completion",,German High-Grade Non-Hodgkin's Lymphoma Study Group,,ALL,ADULT,PHASE3,592,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CDR0000459685|DSHNHL-2004-2|EU-205110|EUDRACT-2005-00521738|DSHNHL-FLYER-6664,2005-11,2018-08,2018-08,2006-01-18,,2021-03-11,"Haematologisch Onkologische Praxis, Aachen, 52070, Germany|Klinikum Augsburg, Augsburg, DOH-86156, Germany|Klinikum Bayreuth, Bayreuth, D-95445, Germany|Haematologisch-Onkologische Schwerpunktpraxis - Weilheim, Berlin, 13357, Germany|Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, D-12200, Germany|Franziskus Hospital, Bielefeld, D-33615, Germany|Augusta-Kranken-Anstalt gGmbH, Bochum, D-44791, Germany|Staedtisches Klinikum Braunschweig, Braunschweig, G-38114, Germany|DIAKO Ev. Diakonie Krankenhaus gGmbH, Bremen, D-28239, Germany|Hospital Kuchwald Chemnitz, Chemnitz, D-09113, Germany|Praxis Fuer Haematologie Internistische Onkologie, Cologne, D-50677, Germany|Medizinische Universitaetsklinik I at the University of Cologne, Cologne, D-50924, Germany|Carl - Thiem - Klinkum Cottbus, Cottbus, D-03048, Germany|Praxis Dr. Rheinhold Siegmund - Dr. Matthias Penke, Damme, D-49401, Germany|Klinikum Dortmund, Dortmund, D-44137, Germany|Hans - Susemihl - Krankenhaus, Emden, 26721, Germany|St. Antonius Hospital, Eschweiler, DOH-52249, Germany|Universitaetsklinikum Essen, Essen, D-45122, Germany|Klinikum Frankfurt (Oder) GmbH, Frankfurt (Oder), D-15236, Germany|Universitaetsklinikum Freiburg, Freiburg, D-79106, Germany|Klinikum Fulda, Fulda, D-36013, Germany|Saint Josef Hospital, Gelsenkirchen, D-45899, Germany|Universitaetsklinikum Goettingen, Goettingen, D-37075, Germany|Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald, D-17475, Germany|Kreiskrankenhaus Gummersbach GMBH, Gummersbach, D-51643, Germany|St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH, Hagen, D-58095, Germany|St. Sixtus Hospital, Haltern, D-45721, Germany|Asklepios Klinik St. Georg, Hamburg, D-20099, Germany|University Medical Center Hamburg - Eppendorf, Hamburg, D-20246, Germany|Haematologisch-Onkologische Praxis Altona, Hamburg, D-22767, Germany|St. Marien-Hospital Hamm - Klinik Knappenstrasse, Hamm, D-59071, Germany|Evangelische Krankenhaus Hamm, Hamm, DOH-59063, Germany|Medizinische Hochschule Hannover, Hannover, D-30625, Germany|Ruprecht - Karls - Universitaet Heidelberg, Heidelberg, 69115, Germany|St. Bernward Krankenhaus, Hildesheim, D-31134, Germany|Universitaetsklinikum des Saarlandes, Homburg, D-66424, Germany|Clinic for Bone Marrow Transplantation and Hematology and Oncology, Idar-Oberstein, D-55743, Germany|Staedtisches Klinikum Karlsruhe gGmbH, Karlsruhe, 76133, Germany|St. Vincentius - Kliniken, Karlsruhe, D-76137, Germany|Klinikum Kempten Oberallgaeu, Kempten, D-87439, Germany|University Hospital Schleswig-Holstein - Kiel Campus, Kiel, D-24116, Germany|Caritas - Krakenhaus Lebach, Lebach, 66822, Germany|Klinikum Lippe - Lemgo, Lemgo, D-32657, Germany|St. Vincenz Hospital Limburg, Limburg, D-65549, Germany|Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, D-67063, Germany|Kreiskrankenhaus Luedenscheid, Luedenscheid, 58515, Germany|Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg, Magdeburg, D-39120, Germany|III Medizinische Klinik Mannheim, Mannheim, D-68305, Germany|Universitaetsklinikum Giessen und Marburg GmbH - Marburg, Marburg, D-35033, Germany|Krankenhaus Ludmillenstift, Meppen, 49716, Germany|Krankenhaus Maria Hilf GmbH, Moenchengladbach, D-41063, Germany|Haematologisch - Onkologische Gemeinschaftspraxis - Muenster, Muenster, D-48149, Germany|Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster, Muenster, D-48149, Germany|Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, D-81377, Germany|Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich, D-81675, Germany|Klinikum Schwaebisch Gmuend Stauferklinik, Mutlangen, D-73557, Germany|Onkologische Schwerwpunktpraxis Dr. Ladda, Neumarkt, D-92318, Germany|Lukaskrankenhaus Neuss, Neuss, D-41464, Germany|Schlossbergkliniken Oberstaufen, Oberstaufen, D-87534, Germany|Klinikum Oldenburg, Oldenburg, D-26133, Germany|Pforzheim, 75179, Germany|Klinikum Ernst Von Bergmann, Potsdam, D-14467, Germany|Prosper-Hospital Recklinghausen, Recklinghausen, DOH-45659, Germany|Rostock, D-18257, Germany|St. Marien - Krankenhaus Siegen GMBH, Siegen, D-57072, Germany|Diakonie Klinikum Stuttgart, Stuttgart, D-70176, Germany|Krankenanstalt Mutterhaus der Borromaerinnen, Trier, D-54219, Germany|Southwest German Cancer Center at Eberhard-Karls-University, Tuebingen, D-72076, Germany|Universitaetsklinikum Tuebingen, Tuebingen, D-72076, Germany|Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, Ulm, D-89081, Germany|St. Marienhospital - Vechta, Vechta, D-49377, Germany|Onkologische Schwerpunktpraxis, Wendlingen, 73240, Germany|Dr. Horst-Schmidt-Kliniken, Wiesbaden, D-65199, Germany|Helios Kliniken Wuppertal University Hospital, Wuppertal, D-42283, Germany|Rabin Medical Center - Beilinson Campus, Petah-Tikva, 49100, Israel|Ospedale Civile - Piacenza, Piacenza, 29100, Italy|Arcispedale S. Maria Nuova, Reggio Emilia, 42100, Italy|Cellulari ed Ematologia Sapienza, Roma, 00161, Italy",
